Table 4.

Changes in HCFS score, PSQI Global score, LYMQOL-ARM score, Global health status from baseline to the end of CDT treatment

	Baseline Mean ± SD	After CDT treatment Mean ± SD	Mean difference (95% CI)	p* value
HCFS score	47.64 ± 15.54	34.37 ± 11.96	11.35 to 15.18	< 0.001
PSQI Global Score	8.21 ± 4.28	5.70 ± 2.35	2.01 to 3.00	< 0.001
LYMQOL-ARM score	59.10 ± 17.71	43.05 ± 11.88	13.89 to 18.18	< 0.001
Global health status	5.13 ± 1.83	6.95 ± 1.32	− 2.15 to − 1.47	< 0.001

* Paired samples t-test, HCFS, Hirai Cancer Fatigue Scale; PSQI, Pittsburgh Sleep Quality Index; LYMQOL, Lymphedema-specific Quality of Life; CDT, complete decongestive therapy